CBPO China Biologic Products Inc.
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
- 26.76 P/E
- 7.35 P/S
- 8.62 P/B
- 2.538 EPS
- 40.69% Cash ROIC
- 2.38 Cash Ratio
- 0 / 0% Dividend
- 75,540.00 Avg. Vol.
- 27.57M Shares
- 1.676B Market Cap.
China Biologic Products, Inc., a biopharmaceutical company, engages in the research, development, production, and manufacture of plasma-based pharmaceutical products in the People's Republic of China. It offers Human Albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and...
Seeking Alpha (registration) - Nov 6, 2014
Forbes - Oct 13, 2014
Seeking Alpha (registration) - Aug 5, 2014
Dakota Financial News - Jan 27, 2015
Stafford Daily - Jan 23, 2015
PR Newswire (press release) - Nov 3, 2014
Zacks.com - Aug 19, 2014
Seeking Alpha (registration) - Sep 22, 2014
Seeking Alpha (registration) - Aug 11, 2014
Ashburn Daily - Jan 21, 2015